Organogenesis Holdings (ORGO) Non-Current Assets (2015 - 2026)

Organogenesis Holdings (ORGO) recorded quarterly Non-Current Assets of $251.5 million in Q1 2026, up 6.32% quarter-over-quarter from $236.5 million in Q4 2025, and up 26.23% on a YoY basis from $199.2 million in Q1 2025.

Organogenesis Holdings (ORGO) Non-Current Assets (2015 - 2026) Analysis & Trends

Organogenesis Holdings' Non-Current Assets history runs 12 years deep, the most recent figure standing at $251.5 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 26.23% year-over-year to $251.5 million; the TTM figure through Mar 2026 stood at $899.0 million (up 8.59% YoY), while the FY2025 annual figure was $236.5 million, up 11.61% from the prior year.
  • Non-Current Assets was $251.5 million for Q1 2026 at Organogenesis Holdings, up from $236.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $251.5 million in Q1 2026 to a low of $199.2 million in Q1 2025.
  • Historically, Non-Current Assets has averaged $223.0 million across 5 years, with a median of $226.7 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 63.07% in 2022, then dropped 13.87% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $226.8 million in 2022, then climbed by 3.63% to $235.0 million in 2023, then fell by 9.8% to $211.9 million in 2024, then increased by 11.61% to $236.5 million in 2025, then grew by 6.32% to $251.5 million in 2026.
  • The last three Non-Current Assets figures came in at $251.5 million (Q1 2026), $236.5 million (Q4 2025), and $210.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 26.33 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.90 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.40 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.22 Bn
10 Organogenesis Holdings 304.80 Mn 212.70 Mn 11.46 Mn 251.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 251.49 Mn
Dec 31, 2025 236.54 Mn
Sep 30, 2025 210.08 Mn
Jun 30, 2025 200.91 Mn
Mar 31, 2025 199.23 Mn
Dec 31, 2024 211.95 Mn
Sep 30, 2024 207.79 Mn
Jun 30, 2024 208.97 Mn
Mar 31, 2024 231.31 Mn
Dec 31, 2023 234.98 Mn
Sep 30, 2023 237.07 Mn
Jun 30, 2023 233.88 Mn
Mar 31, 2023 229.29 Mn
Dec 31, 2022 226.75 Mn
Sep 30, 2022 226.75 Mn
Jun 30, 2022 224.81 Mn
Mar 31, 2022 218.42 Mn
Dec 31, 2021 216.28 Mn
Sep 30, 2021 158.59 Mn
Jun 30, 2021 153.80 Mn